参考文献/References:
[1] de Campos Mazo DF,de Vasconcelos GB,Pereira MA,et al. Clinical spectrum and therapeutic approach to hepatocellular injury in patients with hyperthyroidism[J].Clin Exp Gastroenterol,2013,6:9-17.DOI:10.2147/CEG.S39358.
[2] Kibirige D,Kiggundu DS,Sanya R,et al.Cholestatic hepatic injury due to a thyroid storm: a case report from a resource limited setting[J].Thyroid Res,2012,5(1):6.DOI:10.1186/1756-6614-5-6.
[3] Wang R,Tan J,Zhang G,et al.Risk factors of hepatic dysfunction in patients with Graves' hyperthyroidism and the efficacy of 131iodine treatment[J].Medicine(Baltimore),2017,96(5):e6035.DOI:10.1097/MD.0000000000006035.
[4] Antón Aranda E.Intrahepatic cholestasis in untreated hyperthyroidism[J].Rev Esp Enferm Dig,2000,92(1):49-50.
[5] Khemichian S,Fong TL.Hepatic dysfunction in hyperthyroidism[J].Gastroenterol Hepatol(N Y),2011,7(5):337-339.
[6] Pasyechko NV,Kuleshko II,Kulchinska VM,et al. Ultrastructural liver changes in the experimental thyrotoxicosis[J].Pol J Pathol,2017,68(2):144-147.DOI:10.5114/pjp.2017.69690.
[7] Videla LA, Fernández V, Cornejo P,et al. Causal role of oxidative stress in unfolded protein response development in the hyperthyroid state[J].Free Radic Biol Med,2015,89:401-408. DOI:10.1016/j.freeradbiomed.2015.09.004.
[8] Vargas-Uricoechea H,Bonelo-Perdomo A,Sierra-Torres CH. Effects of thyroid hormones on the heart[J].Clin Investig Arterioscler,2014,26(6):296-309.DOI:10.1016/j.arteri.2014.07.003.
[9] Osuna PM,Udovcic M,Sharma MD.Hyperthyroidism and the Heart[J].Methodist Debakey Cardiovasc J,2017,13(2):60-63.DOI:10.14797/mdcj-13-2-60.
[10] Hui TY,Bruyette DS,Moore GE,et al.Effect of feeding an iodine-restricted diet in cats with spontaneous hyperthyroidism[J].J Vet Intern Med,2015,29(4):1063-1068.DOI:10.1111/jvim.13368.
[11] Heidari R,Niknahad H,Jamshidzadeh A,et al.An overview on the proposed mechanisms of antithyroid drugs-induced liver injury[J].Adv Pharm Bull,2015,5(1):1-11.DOI:10.5681/apb.2015.001.
[12] Van Steenbergen W,Fevery J,De Groote J.Thyroid hormones and the hepatic handling of bilirubin.Ⅱ. Effects of hypothyroidism and hyperthyroidism on the apparent maximal biliary secretion of bilirubin in the Wistar rat[J].J Hepatol,1988,7(2):229-238.
相似文献/References:
[1]朱丹,陈国芳,刘超,等.糖尿病患者合并甲状腺功能异常的机制
及其影响[J].国际内分泌代谢杂志,2016,36(03):206.[doi:10.3760/cma.j.issn.1673-4157.2016.03.16]
Zhu Dan*,Chen Guofang,Liu Chao,et al.Mechanisms of diabetes combined with thyroid dysfunction and its influence[J].International Journal of Endocrinology and Metabolism,2016,36(01):206.[doi:10.3760/cma.j.issn.1673-4157.2016.03.16]
[2]韩煦,魏军平.促甲状腺激素受体抗体的检测及其在Graves病
诊疗中的价值[J].国际内分泌代谢杂志,2017,37(02):94.[doi:10.3760/cma.j.issn.1673-4157.2017.02.006]
Han Xu,Wei Junping..Thyroid stimulating hormone receptor antibodies assays and its clinical significance in Graves' disease[J].International Journal of Endocrinology and Metabolism,2017,37(01):94.[doi:10.3760/cma.j.issn.1673-4157.2017.02.006]
[3]郑仁东 张会峰 胡咏新 曹雯 曹琳 孙洪平 褚晓秋 刘克冕 刘超.男性2型糖尿病患者甲状腺结节
与内分泌激素的相关性研究[J].国际内分泌代谢杂志,2018,38(04):222.[doi:10.3760/cma.j.issn.1673-4157.2018.04.002]
Zheng Rendong,Zhang Huifeng,Hu Yongxin,et al.Association of thyroid nodules with endocrine hormones in male patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(01):222.[doi:10.3760/cma.j.issn.1673-4157.2018.04.002]
[4]周鹏 张少红 韦晓 陈国芳 刘超.季节性变化对甲状腺激素的影响[J].国际内分泌代谢杂志,2019,39(05):349.[doi:10.3760/cma.j.issn.1673-4157.2019.05.015]
Zhou Peng,Zhang Shaohong,Wei Xiao,et al.Effects of seasonal changes on thyroid hormones[J].International Journal of Endocrinology and Metabolism,2019,39(01):349.[doi:10.3760/cma.j.issn.1673-4157.2019.05.015]
[5]张小改 陈国芳 徐书杭 张芳 刘超.甲状腺激素与肥胖:孰因孰果?[J].国际内分泌代谢杂志,2020,40(02):129.[doi:10.3760/cma.j.issn.1673-4157.2020.02.014]
Zhang Xiaogai,Chen Guofang,Xu Shuhang,et al.Thyroid hormone and obesity:cause or consequence?[J].International Journal of Endocrinology and Metabolism,2020,40(01):129.[doi:10.3760/cma.j.issn.1673-4157.2020.02.014]
[6]姚瑶,郑仁东,刘超.血浆置换治疗甲状腺功能亢进症的研究进展[J].国际内分泌代谢杂志,2020,40(05):320.[doi:10.3760/cma.j.cn121383-20191218-12047]
Yao Yao,Zheng Rendong,Liu Chao.Update on plasmapheresis for hyperthyroidism[J].International Journal of Endocrinology and Metabolism,2020,40(01):320.[doi:10.3760/cma.j.cn121383-20191218-12047]
[7]刘天琪,张秀英,纪立农.促甲状腺激素受体抗体的检测及应用进展[J].国际内分泌代谢杂志,2021,41(01):5.[doi:10.3760/cma.j.cn121383-20200608-06021]
Liu Tianqi,Zhang Xiuying,Ji Linong..Progression of assay and clinical practice of thyroid stimulating hormone receptor antibody[J].International Journal of Endocrinology and Metabolism,2021,41(01):5.[doi:10.3760/cma.j.cn121383-20200608-06021]
[8]应瑞雪,艾李雅,章诗琪,等.2型糖尿病患者血清正常范围的甲状腺激素水平与肌少症的相关性研究[J].国际内分泌代谢杂志,2022,42(02):114.[doi:10.3760/cma.j.cn121383-20200307-03016]
Ying Ruixue,Ai Liya,Zhang shiqi,et al.Correlation between normal serum thyroid hormone levels and sarcopenia in patients with type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2022,42(01):114.[doi:10.3760/cma.j.cn121383-20200307-03016]
[9]朱航毅,赵一璟,史雨清,等.碳酸锂致肾性尿崩症的研究进展[J].国际内分泌代谢杂志,2022,42(06):485.[doi:10.3760/cma.j.cn121383-20210530-05078]
Zhu Hangyi,Zhao Yijing,Shi Yuqing,et al.Research progress of nephrogenic diabetes insipidus induced by carbonate lithium[J].International Journal of Endocrinology and Metabolism,2022,42(01):485.[doi:10.3760/cma.j.cn121383-20210530-05078]
[10]曾晓娇,田玲,孙毅娜.Allan-Herndon-Dudley综合征诊疗现状[J].国际内分泌代谢杂志,2023,43(04):336.[doi:10.3760/cma.j.cn121383-20220926-09047]
Zeng Xiaojiao,Tian Ling,Sun Yina.Diagnosis and treatment of Allan-Herndon-Dudley syndrome[J].International Journal of Endocrinology and Metabolism,2023,43(01):336.[doi:10.3760/cma.j.cn121383-20220926-09047]
[11]朱萍,卫红艳,王坤玲,等.Graves病甲状腺功能亢进症性肝损害的
相关因素分析[J].国际内分泌代谢杂志,2017,37(03):164.[doi:10.3760/cma.j.issn.1673-4157.2017.03.005]
Zhu Ping,Wei Hongyan,Wang Kunling,et al.Related factors of hyperthyroidism-related liver dysfunction in Graves' disease[J].International Journal of Endocrinology and Metabolism,2017,37(01):164.[doi:10.3760/cma.j.issn.1673-4157.2017.03.005]